Effects of Estradiol Valerate on Splenocyte Apoptosis and Ovarian Function of Climacteric Rats

ZHANG Shao-fen,XIE Qian,HA Ling-xia,LIU Yang,XIA Xian,LIU Rei-zi,LIU Jian-hua
DOI: https://doi.org/10.3969/j.issn.1004-3845.2006.06.008
2006-01-01
Journal of reproductive medicine
Abstract:Objective: To evaluate the effects of estradiol valerate on splenocyte apoptosis and ovarian histomorphology of menopausal rats. Methods: Thirty female SD rats were divided into three groups: young group(2.5 months old) and climacteric group(12 months old), with distilled water 1 ml/d, po; estrogen-treated group (12 months old), with estradiol valerate 800 μg·kg -1 ·d -1 , po. Three months later serum E_2 levels were measured by RIA.The splenocyte apoptosis of rats was measured by Annexin V-FITC/PI flow cytometric assay. Bcl-2 and Bax gene expressions were detected by RT-PCR. Bilateral ovarian samples were sectioned and followed by histomorphometry observation with IMS auto-image-assays system. Results: The climacteric rats had significantly lower serum E_2 levels and higher rates of splenocyte apoptosis than those of young group, and the higher rates of splenocyte apoptosis were associated with the higher expression of Bax genes in the climacteric rats. The serum E_2 levels of estrogen group were obviously higher than those of both young and climacteric groups. The rates of splenocyte apoptosis in estrogen group were also higher than those of the young group, which was associated with the higher expression of Bax genes and the lower expression of Bcl-2 genes in estrogen group. The expression of Bcl-2 genes of the estrogen group was also lower than that of climacteric group. Histomorphometry assay showed the climacteric and estrogen-treated groups had lower counts of corpus luteum and less vertical section areas of ovaries than those in young group. Conclusions: The age-related changes of splenocyte apoptosis in the climacteric rats were negatively associated with plasma estradiol levels and could not be reversed by the supraphysiological levels of estrogen exposure, which might be associated with irreversible aging of ovarian function.
What problem does this paper attempt to address?